Daniel Beriault

Head of Biochemistry

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Beriault is the Head of Biochemistry at Unity Health Toronto, Canada. His research focuses on clinical biochemistry, including age-specific reference intervals for neurofilament assays, environmental sustainability in laboratory practices, and the assessment of cardiac troponin for myocardial infarction diagnostics. He has published extensively on topics related to laboratory practices, including oligoclonal banding in CSF analysis and the impact of new psychoactive substances on clinical laboratory settings.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Beriault

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Assessing Analytical Performance and Correct Classification for Cardiac Troponin Deltas Across Diagnostic Pathways Used for Myocardial Infarction

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay

Green laboratory practice: Top 2 environmental recommendations for clinical laboratories

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care

A review of laboratory practices for CSF oligoclonal banding and associated tests

A survey of Canadian neurologists’ perspectives and preferences for laboratory reporting of CSF oligoclonal banding

Oligoclonal banding analysis: Assessing plasma use and time interval requirements for paired CSF and blood

‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation

New psychoactive Substances: A Canadian perspective on emerging trends and challenges for the clinical laboratory

Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories

The origin of ferritin reference intervals: a systematic review

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac Troponin

Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study

Validating the NIH LDL-C equation for provincial implementation in Alberta

A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism

Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences

Variation in processes and reporting of cerebrospinal fluid oligoclonal banding and associated tests and calculated indices across Canadian clinical laboratories

Collaborators (5)

Michael Knauer

Paul Yip

neville suskin

Karina Rodriguez-Capote

Eliane Shore

Make your next move.